Latest News of CAPL
Johnson & Johnson Submits Schizophrenia Drug CAPLYTA sNDA to FDA Based on Positive Relapse Prevention Data
By Yahoo! Finance | 1 week ago
Johnson & Johnson (NYSE:JNJ) Submits sNDA For Schizophrenia Drug CAPLYTA® To FDA
By Yahoo! Finance | 1 week ago